Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Sands during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Protagonist Therapeutics, Inc.
- Tr1X, Inc.
- Boehringer Ingelheim Corporation
- Target RWE
- Equilium, Inc.
- Teva Branded Pharmaceutical Products R&D, Inc.
- Eli Lilly and Company
- Adiso Therapeutics USA
- Synlogic
- Alimentiv
- AstraZeneca
- Takeda Development Center Americas, Inc.
- Amgen Inc.
- Cowen Services
- Galapagos
- Bristol-Myers Squibb
- Janssen Pharmaceutica NV
- Morphic Therapeutic
- Prometheus Biosciences
- Immunyx Pharma
- Kallyope
- VectivBio AG
- Takeda Pharmaceuticals International AG
- Genentech, Inc.
- Glaxosmithkline
- Televant
- WebMD
- MJH Healthcare Holdings
- Clinical Care Options, LLC (CCO)
- Immunic
- Progenity, Inc.
- Ferring Pharmaceuticals
- Vindico Medical Education
- Aclaris Therapeutics
- Janssen Research & Development, LLC
- Celltrion
- Pfizer Australia Holdings PTY Limited
- Takeda Distribuidora, Ltd.
- Agomab Therapeutics
- Integritas Communications, LLC
- FirstThought
- Materia Prima
- Kyowa Kirin, Inc.
- Prometheus Laboratories
- Merck Sharp & Dohme Corp
- AnaptysBio, Inc
- Abivax
- Imhotex
- AbbVie Inc.
- MRM Health NV
- EcoR1 Capital
- Janssen Research & Development
- Microbiotica Limited
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Alfasigma S.p.A.
- Ventyx Biosciences
- Pfizer Inc., U.S. Pharmaceuticals Group
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Sands during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Protagonist Therapeutics, Inc.
- Tr1X, Inc.
- Boehringer Ingelheim Corporation
- Target RWE
- Equilium, Inc.
- Teva Branded Pharmaceutical Products R&D, Inc.
- Eli Lilly and Company
- Adiso Therapeutics USA
- Synlogic
- Alimentiv
- AstraZeneca
- Takeda Development Center Americas, Inc.
- Amgen Inc.
- Cowen Services
- Galapagos
- Bristol-Myers Squibb
- Janssen Pharmaceutica NV
- Morphic Therapeutic
- Prometheus Biosciences
- Immunyx Pharma
- Kallyope
- VectivBio AG
- Takeda Pharmaceuticals International AG
- Genentech, Inc.
- Glaxosmithkline
- Televant
- WebMD
- MJH Healthcare Holdings
- Clinical Care Options, LLC (CCO)
- Immunic
- Progenity, Inc.
- Ferring Pharmaceuticals
- Vindico Medical Education
- Aclaris Therapeutics
- Janssen Research & Development, LLC
- Celltrion
- Pfizer Australia Holdings PTY Limited
- Takeda Distribuidora, Ltd.
- Agomab Therapeutics
- Integritas Communications, LLC
- FirstThought
- Materia Prima
- Kyowa Kirin, Inc.
- Prometheus Laboratories
- Merck Sharp & Dohme Corp
- AnaptysBio, Inc
- Abivax
- Imhotex
- AbbVie Inc.
- MRM Health NV
- EcoR1 Capital
- Janssen Research & Development
- Microbiotica Limited
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Alfasigma S.p.A.
- Ventyx Biosciences
- Pfizer Inc., U.S. Pharmaceuticals Group
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
